NCT05723614 TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
| NCT ID | NCT05723614 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Firearm Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 61,770 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 61,770 participants in total. It began in 2023-02-01 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective of this study is to implement and test a strengths-based, community-driven intervention to reduce gun violence by (1) improving housing stability through providing financial assistance coupled with comprehensive financial education for the re-entry population as well as their family members, and (2) fostering greater support for mental health by training a trusted network of community members in trauma-informed counseling.
Eligibility Criteria
All residents in the study neighborhoods are eligible for outcome assessment. For the intervention component of housing support, the below inclusion and exclusion criteria apply. Inclusion criteria: * Age 18 or above * Family member currently incarcerated or person returning from prison within the last 12 months * Live in one of the seven neighborhoods with highest rates of gun violence in New Haven, Connecticut Exclusion criteria: * Plans to leave the study area within 1 year
Contact & Investigator
Emily Wang, MD, MAS
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT05723614 clinical trial?
This trial is open to participants of all sexes, studying Firearm Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05723614 currently recruiting?
Yes, NCT05723614 is actively recruiting participants. Contact the research team at emily.wang@yale.edu for enrollment information.
Where is the NCT05723614 trial being conducted?
This trial is being conducted at New Haven, United States, New Haven, United States, New Haven, United States, New Haven, United States and 3 additional locations.
Who is sponsoring the NCT05723614 clinical trial?
NCT05723614 is sponsored by Yale University. The principal investigator is Emily Wang, MD, MAS at Yale University. The trial plans to enroll 61,770 participants.